✦ LIBER ✦

PCN91 ARTHRALGIA AND PATIENT-REPORTED OUTCOMES IN POSTMENOPAUSAL WOMEN WITH EARLY BREAST CANCER TAKING AROMATASE INHIBITORS: LONGITUDINAL ANALYSES

✍ Scribed by L.D. Castel; I.A. Mayer; H. Chen; S.E. McLellan; S.A. Deppen; V.G. Abramson; C.S. Boomershine; D.L. Friedman; C.M. Gundy; W.R. Lenderking; K.E. Hartmann; D.H. Johnson; D.F. Cella

Book ID: 119309702
Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 58 KB
Volume: 14
Category: Article
ISSN: 1098-3015
DOI: 10.1016/j.jval.2011.02.946

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Aromatase Inhibitors in the Adjuvant Tre

Aromatase Inhibitors in the Adjuvant Treatment of Postmenopausal Women with Early Breast Cancer: Putting Safety Issues into Perspective

✍ PierFranco Conte; Antonio Frassoldati 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 466 KB

Do adjuvant aromatase inhibitors increas

Do adjuvant aromatase inhibitors increase the cardiovascular risk in postmenopausal women with early breast cancer : Meta-analysis of randomized trials

✍ Federica Cuppone; Emilio Bria; Sunil Verma; Kathleen I. Pritchard; Sonal Gandhi; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 203 KB 👁 1 views

## Abstract ## BACKGROUND. Despite the advantages from using aromatase inhibitors (AIs) compared with tamoxifen for early breast cancer, an unexpectedly greater number of grade 3 and 4 cardiovascular events (CVAE) (as defined by National Cancer Institute of Canada‐Common Toxicity Criteria [version